Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Current HIV Research|August 6, 2016
HIV Infection and Myocardial InfarctionLeonardo Calza
HIV Clinical Trials|August 2, 2012
Renal toxicity associated with antiretroviral therapyLeonardo Calza
Drug, Healthcare and Patient Safety|June 25, 2011
Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemicsLeonardo Calza
Recenti Progressi in Medicina|February 28, 2006
["Mad cow" disease: scientific novelty or academic terrorism?]Roberto Manfredi, Leonardo Calza
AIDS Patient Care and Stds|February 23, 2008
Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patientsRoberto Manfredi, Leonardo Calza
AIDS (London, England)|November 7, 2006
Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/microlRoberto Manfredi, Leonardo Calza
Current HIV Research|September 29, 2012
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infectionLeonardo Calza, Roberto Manfredi
Le Infezioni in Medicina|April 22, 2003
[HIV genotypic mutation selectively induced by the protease inhibitor nelfinavir at codon 30. Case series and consequences for antiretroviral management]Roberto Manfredi, Leonardo Calza
Recenti Progressi in Medicina|December 2, 2008
[Two novel fixed formulations of nucleoside analogues (tenofovir-emtricitabine, and abacavir-lamivudine). Prospective, open study on clinical practice and therapeutic perspectives, in patients naïve and in subjects pre-treated with antiretrovirals]Roberto Manfredi, Leonardo Calza
Recenti Progressi in Medicina|February 25, 2010
[Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy]Roberto Manfredi, Leonardo Calza
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Current HIV Research|August 6, 2016
HIV Infection and Myocardial InfarctionLeonardo Calza
HIV Clinical Trials|August 2, 2012
Renal toxicity associated with antiretroviral therapyLeonardo Calza
Drug, Healthcare and Patient Safety|June 25, 2011
Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemicsLeonardo Calza
Recenti Progressi in Medicina|February 28, 2006
["Mad cow" disease: scientific novelty or academic terrorism?]Roberto Manfredi, Leonardo Calza
AIDS Patient Care and Stds|February 23, 2008
Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patientsRoberto Manfredi, Leonardo Calza
AIDS (London, England)|November 7, 2006
Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/microlRoberto Manfredi, Leonardo Calza
Current HIV Research|September 29, 2012
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infectionLeonardo Calza, Roberto Manfredi
Le Infezioni in Medicina|April 22, 2003
[HIV genotypic mutation selectively induced by the protease inhibitor nelfinavir at codon 30. Case series and consequences for antiretroviral management]Roberto Manfredi, Leonardo Calza
Recenti Progressi in Medicina|December 2, 2008
[Two novel fixed formulations of nucleoside analogues (tenofovir-emtricitabine, and abacavir-lamivudine). Prospective, open study on clinical practice and therapeutic perspectives, in patients naïve and in subjects pre-treated with antiretrovirals]Roberto Manfredi, Leonardo Calza
Recenti Progressi in Medicina|February 25, 2010
[Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy]Roberto Manfredi, Leonardo Calza
Pageof 19